Literature DB >> 31150688

Lysosomal dysfunction induced by changes in albumin's tertiary structure: Potential key factor in protein toxicity during diabetic nephropathy.

Rafael Medina-Navarro1, Yessica Dorin Torres-Ramos2, Alberto Martin Guzmán-Grenfell2, Margarita Díaz-Flores3, Guadalupe León-Reyes2, Juan José Hicks G4.   

Abstract

AIMS: Increased amounts of protein, in particular albumin within renal tubular cells (TBCs), induce the expression of inflammatory and fibrogenic mediators, which are adverse prognostic factors in tubulointerstitial fibrosis and diabetic nephropathy (DN). We sought to assess the participation of the thiol-linked tertiary structure of albumin in the mechanism of protein toxicity in a model of TBCs.
MATERIALS AND METHODS: Cultured human renal proximal tubular cells, HK-2, were exposed to isolated albumin from patients with and without DN (Stages 0, 1 and 4). The magnitude of change of the albumin tertiary structure, cell viability (LDH leakage), apoptosis (Annexin V), transdifferentiation and reticulum endoplasmic stress (Western blot and flow cytometry) and lysosomal enzyme activity were assessed. KEY
FINDINGS: We found that albumin from Stage 4 patients presented >50% higher thiol-dependent changes of tertiary structure compared to Stages 0 and 1. Cells incubated with Stage 4 albumin displayed 5 times less viability, accompanied by an increased number of apoptotic cells; evidence of profibrogenic markers E-cadherin and vimentin and higher expression of epithelial-to-mesenchymal transition markers α-SMA and E-cadherin and of endoplasmic reticulum stress protein GRP78 were likewise observed. Moreover, we found that cathepsin B activity in isolated lysosomes showed a significant inhibitory effect on albumin from patients in advanced stages of DN and on albumin that was intentionally modified. SIGNIFICANCE: Overall, this study showed that thiol-dependent changes in albumin's tertiary structure interfere with the lysosomal proteolysis of renal TBCs, inducing molecular changes associated with interstitial fibrosis and DN progression.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Albumin structure; Cathepsin B; Diabetic nephropathy; Lysosomal proteolysis; Renal interstitial fibrosis

Mesh:

Substances:

Year:  2019        PMID: 31150688     DOI: 10.1016/j.lfs.2019.05.069

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  6 in total

1.  Mapping Adverse Outcome Pathways for Kidney Injury as a Basis for the Development of Mechanism-Based Animal-Sparing Approaches to Assessment of Nephrotoxicity.

Authors:  Angela Mally; Sebastian Jarzina
Journal:  Front Toxicol       Date:  2022-06-15

2.  The effect of repeated passaging on the susceptibility of human proximal tubular HK-2 cells to toxic compounds.

Authors:  J Handl; J Čapek; P Majtnerová; J Báčová; T Roušar
Journal:  Physiol Res       Date:  2020-07-16       Impact factor: 1.881

3.  Mechanism of how carbamylation reduces albumin binding to FcRn contributing to increased vascular clearance.

Authors:  Shiv Pratap S Yadav; Ruben M Sandoval; Jingfu Zhao; Yifan Huang; Exing Wang; Sudhanshu Kumar; Silvia B Campos-Bilderback; George Rhodes; Yehia Mechref; Bruce A Molitoris; Mark C Wagner
Journal:  Am J Physiol Renal Physiol       Date:  2020-12-07

4.  Activation of Transcription Factor EB Alleviates Tubular Epithelial Cell Injury via Restoring Lysosomal Homeostasis in Diabetic Nephropathy.

Authors:  Shujun Wang; Kaipeng Jing; Hongluan Wu; Xiaoyu Li; Chen Yang; Tingting Li; Haoxuan Tang; Ting Zou; Yao She; Hua-Feng Liu
Journal:  Oxid Med Cell Longev       Date:  2022-01-12       Impact factor: 6.543

Review 5.  Relationship between lysosomal dyshomeostasis and progression of diabetic kidney disease.

Authors:  Man Wu; Minjie Zhang; Yaozhi Zhang; Zixian Li; Xingyu Li; Zejian Liu; Huafeng Liu; Xiaoyu Li
Journal:  Cell Death Dis       Date:  2021-10-18       Impact factor: 8.469

6.  GSK3β-dependent lysosome biogenesis: An effective pathway to mitigate renal fibrosis with LM49.

Authors:  Jinhong Ren; Huizhi Wei; Jian Sun; Xiue Feng; Yuanlin Zhang; Hongxia Yuan; Junqiu Miao; Xiaoming Qi; Yuanbiao Qiao; Baoguo Xiao; Qingshan Li
Journal:  Front Pharmacol       Date:  2022-09-26       Impact factor: 5.988

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.